U.S. Markets close in 5 hrs 50 mins

Amgen: Analysts’ Recommendations on October 25

Mike Benson
Amgen: Analysts’ Recommendations on October 25

Wall Street analysts expect Amgen’s (AMGN) revenues to decrease marginally by ~0.1% to $5.769 billion during the third quarter—compared to revenues of $5.773 billion during the third quarter of 2017. The EPS is estimated to be $3.45 for the third quarter—compared to the EPS of $3.27 for the third quarter of 2017.